The discrimination of dyslipidaemia using anthropometric measures in ethnically diverse populations of the Asia–Pacific Region: The Obesity in Asia Collaboration
- 17 January 2010
- journal article
- research article
- Published by Wiley in Obesity Reviews
- Vol. 11 (2), 127-136
- https://doi.org/10.1111/j.1467-789x.2009.00605.x
Abstract
Dyslipidaemia is a major risk factor for cardiovascular disease and is only detectable through blood testing, which may not be feasible in resource-poor settings. As dyslipidaemia is commonly associated with excess weight, it may be possible to identify individuals with adverse lipid profiles using simple anthropometric measures. A total of 222 975 individuals from 18 studies were included as part of the Obesity in Asia Collaboration. Linear and logistic regression models were used to assess the association between measures of body size and dyslipidaemia. Body mass index, waist circumference, waist : hip ratio (WHR) and waist : height ratio were continuously associated with the lipid variables studied, but the relationships were consistently stronger for triglycerides and high-density lipoprotein cholesterol. The associations were similar between Asians and non-Asians, and no single anthropometric measure was superior at discriminating those individuals at increased risk of dyslipidaemia. WHR cut-points of 0.8 in women and 0.9 in men were applicable across both Asians and non-Asians for the discrimination of individuals with any form of dyslipidaemia. Measurement of central obesity may help to identify those individuals at increased risk of dyslipidaemia. WHR cut-points of 0.8 for women and 0.9 for men are optimal for discriminating those individuals likely to have adverse lipid profiles and in need of further clinical assessment.Keywords
This publication has 18 references indexed in Scilit:
- Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deathsThe Lancet, 2007
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsThe Lancet, 2005
- The metabolic syndrome—a new worldwide definitionThe Lancet, 2005
- Ethnic comparisons of obesity in the Asia‐Pacific region: protocol for a collaborative overview of cross‐sectional studiesObesity Reviews, 2005
- A Comparison of Lipid Variables as Predictors of Cardiovascular Disease in the Asia Pacific RegionAnnals of Epidemiology, 2005
- Impact of Obesity and Body Fat Distribution on Cardiovascular Risk Factors in Hong Kong ChineseObesity Research, 2004
- Definition of Metabolic SyndromeCell Metabolism, 2004
- Managing the global burden of cardiovascular diseaseEuropean Heart Journal Supplements, 2002
- Optimal cut-off values for obesity: using simple anthropometric indices to predict cardiovascular risk factors in TaiwanInternational Journal of Obesity, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001